|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
25 March 2024 |
|
Main ID: |
NCT01653392 |
|
Date of registration:
|
16/07/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
BioThrax® (Anthrax) Vaccine in Pregnancy Registry
|
|
Scientific title:
|
BioThrax® (Anthrax) Vaccine in Pregnancy Registry |
|
Date of first enrolment:
|
July 2012 |
|
Target sample size:
|
98 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT01653392 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Natalie Wells, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Naval Health Research Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Female active duty service member
- Received one or more dose of BioThrax while pregnant, with the onset of pregnancy
defined as the first day of the last menstrual period.
Exclusion Criteria:
- Non-service member, non-active duty pregnant female.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Pregnancy Outcome
|
|
Congenital Abnormalities
|
|
Pregnancy Complications
|
|
Intervention(s)
|
|
Biological: Observational Intervention
|
|
Primary Outcome(s)
|
|
Maternal Outcomes
[Time Frame: Up to 44 weeks]
|
|
Infant Outcomes
[Time Frame: Up to 1 year of age]
|
|
Pregnancy Outcomes
[Time Frame: Up to 44 weeks]
|
|
Secondary ID(s)
|
|
EBS.AVA.010 / NHRC.2012.0003
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|